NEW Selling losers for tax season? Check the wash-sale window first
Our free Wash Sale Calculator shows the first day you can buy back — and flags buys that would cancel your tax loss.
Check a trade »

IQV | NYSE

$267.37 -$7.69 | -2.80%
TREND SIGNAL:Signal available — unlock to view |2026-10-30

Company Overview:

Market Cap: $43.84B
Trailing PE: N/A
FWD PE *: 19.3x
Payout Ratio (TTM): —
52-Week Range: $154.50 - $284.50

* Forward PE is based on street estimates.

10 Year IQV Performance Metrics:

Total Return (with DRIP): 273.1% (14.07% CAGR)
Total Return (no DRIP): 273.1% (14.07% CAGR)
Share Price: 273.1% (14.07% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $37,311
Total Return $ (with DRIP): $27,311
IQV Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
IQV Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
Build Custom Charts
IQV - Chart 1
IQV - Chart 2
IQV - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

IQV Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

IQV - Revenue
IQV Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Earnings Per Share (EPS)
IQV EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Net Income
IQV Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - EBITDA
IQV EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Free Cash Flow
IQV Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Free Cash Flow / Share
IQV Free Cash Flow / Share CAGR:1Y: -42.61%2Y: 13.65%5Y: 2.60%10Y: 7.23%
IQV - Operating Income
IQV Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Gross Profit
IQV Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Shares Outstanding
IQV Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Share Buybacks
IQV Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Stock-Based Comp
IQV Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Expenses
IQV Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Revenue by Segment
IQV Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - Revenue by Region
IQV Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

IQV - REVENUE: Actual + Estimates
IQV Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - EPS: Actual + Estimates
IQV Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - NET INCOME: Actual + Estimates
IQV Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
IQV - EBITDA: Actual + Estimates
IQV Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

IQV - Net Profit Margin
IQV Net Profit Margin CAGR:1Y: -2.11%2Y: 3.89%5Y: 0.51%10Y: 1.78%
IQV - Gross Profit Margin
IQV Gross Profit Margin CAGR:1Y: 1.02%2Y: -2.20%5Y: 0.16%10Y: 1.59%
IQV - Price to Earnings
IQV Price to Earnings CAGR:1Y: 28.92%2Y: -8.70%5Y: -6.41%10Y: 2.65%
IQV - Price To Sales Ratio
IQV Price To Sales Ratio CAGR:1Y: 26.82%2Y: -4.98%5Y: -5.86%10Y: 4.50%
IQV - Return on Capital Employed
IQV Return on Capital Employed CAGR:1Y: -7.86%2Y: -3.82%5Y: 9.87%10Y: -9.30%
IQV - Return on Invested Capital
IQV Return on Invested Capital CAGR:1Y: -2.26%2Y: -3.05%5Y: 4.51%10Y: -10.20%

Compare stocks side-by-side

Projected Future Returns & Dividends for IQV

Based on past 10-year performance, here are IQV growth metrics:

Share price CAGR of +14.06%
Dividend CAGR of +0%

Using IQV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

IQV (DRIP)IQV - No DRIP
Current Price$267.37$267.37
Start Shares37.4037.40
Start Value$10,000$10,000
  
After 10 years:
Final Share Count37.4037.40
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$267.37$267.37
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - IQV

NOTE: Above numbers are our estimate based on IQV's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

IQVIA Holdings Inc. (IQV) had its IPO on 2013-05-09, and is traded on NYSE stock exchange.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

IQV website: https://www.iqvia.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF model unavailable for IQV — no fundamentals on file (ETFs and funds are not modelable).